Jiri Navratil

Brno, JM, Czech Republic

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications

Characterization and thermoelectric performance of mechanochemically synthesized Cu-Ag-Se sample series.

Characterization and thermoelectric performance of mechanochemically synthesized Cu-Ag-Se sample series.

Journal: Nanoscale advances
Published: April 17, 2026

Thermal Conductivity of CdCr2Se4 Ferromagnet at Low Temperatures: Role of Grain Boundaries and Porosity.

Thermal Conductivity of CdCr2Se4 Ferromagnet at Low Temperatures: Role of Grain Boundaries and Porosity.

Journal: Langmuir : the ACS journal of surfaces and colloids
Published: March 18, 2026

Circulating tumour cell-derived xenograft as a preclinical platform for metastatic breast cancer.

Circulating tumour cell-derived xenograft as a preclinical platform for metastatic breast cancer.

Journal: British journal of cancer
Published: August 01, 2025

Tropomyosin isoforms encoded by TPM2 control the actin-bundling activity of fascin-1.

Tropomyosin isoforms encoded by TPM2 control the actin-bundling activity of fascin-1.

Journal: Biological research
Published: June 16, 2025

Orchestrating movement: the role of Caveolin-1 in migration and metastasis.

Orchestrating movement: the role of Caveolin-1 in migration and metastasis.

Journal: Molecular cancer
Published: May 30, 2025

Patient-reported Outcomes for Men with Metastatic Castration-resistant Prostate Cancer Who Received Olaparib plus Abiraterone Versus Placebo plus Abiraterone in the Phase 3 PROpel Study.

Patient-reported Outcomes for Men with Metastatic Castration-resistant Prostate Cancer Who Received Olaparib plus Abiraterone Versus Placebo plus Abiraterone in the Phase 3 PROpel Study.

Journal: European urology oncology
Published: March 28, 2025

Adaptor protein CIN85 potentiates the motility of osteosarcoma cells via the Akt/mTOR and MMP2-COL3A1 axis.

Adaptor protein CIN85 potentiates the motility of osteosarcoma cells via the Akt/mTOR and MMP2-COL3A1 axis.

Journal: Molecular oncology
Published: March 25, 2025

Apalutamide in Metastatic Castration-sensitive Prostate Cancer: Results from the Multicenter Real-world ARON-3 Study.

Apalutamide in Metastatic Castration-sensitive Prostate Cancer: Results from the Multicenter Real-world ARON-3 Study.

Journal: European urology oncology
Published: October 02, 2024

Correction: Circulating tumor cell-derived preclinical models: current status and future perspectives.

Correction: Circulating tumor cell-derived preclinical models: current status and future perspectives.

Journal: Cell death & disease
Published: July 02, 2024

Long-term zinc treatment alters the mechanical properties and metabolism of prostate cancer cells.

Long-term zinc treatment alters the mechanical properties and metabolism of prostate cancer cells.

Journal: Cancer cell international
Published: April 23, 2024

Glutamine and serum starvation alters the ATP production, oxidative stress, and abundance of mitochondrial RNAs in extracellular vesicles produced by cancer cells.

Glutamine and serum starvation alters the ATP production, oxidative stress, and abundance of mitochondrial RNAs in extracellular vesicles produced by cancer cells.

Journal: Scientific reports
Published: April 15, 2024

Long-Term Efficacy and Safety of Enzalutamide Monotherapy in Elderly Patients with Metastatic Castration-Resistant Prostate Cancer: A Case Report.

Long-Term Efficacy and Safety of Enzalutamide Monotherapy in Elderly Patients with Metastatic Castration-Resistant Prostate Cancer: A Case Report.

Journal: Case reports in oncology
Published: December 21, 2023
Showing 1-12 of 41

Last Updated: 09/26/2026